Study of Redirected Autologous T Cells Engineered to Contain Anti-CD19 Attached to TCR and 4-1BB Signaling Domains in Patients With Chemotherapy Resistant or Refractory Acute Lymphoblastic Leukemia
Clinical trial NCT02030847 · COMPLETED
Trial details
- NCT number
- NCT02030847
- Sponsor
- University of Pennsylvania
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-27
- Primary completion
- 2018-04-26
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.